<DOC>
	<DOCNO>NCT01644656</DOCNO>
	<brief_summary>The aim diagnostic study evaluate efficacy ARFI imaging ( specific type ultrasound ) assess pressure portal vein ( major vein pass liver ) amount liver fibrosis patient chronic liver disease .</brief_summary>
	<brief_title>Non-invasive Diagnosis Portal Hypertension With Acoustic Radiation Force Impulse ( ARFI )</brief_title>
	<detailed_description>DESIGN The study design prospective , cross-sectional , diagnostic study investigator evaluate use ARFI diagnose clinically significant portal hypertension ( CSPH define hepatic veous pressure gradient ( HVPG ) great 10 mmHg ) , take HVPG measurement gold standard . METHODOLOGY - The study perform VA Connecticut Healthcare System-West Haven Yale . - Study population recruit among patient VA/Yale Liver Clinics outside hospital refer VA/Yale transjugular liver biopsy hepatic venous pressure gradient measurement part routine care .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Hypertension , Portal</mesh_term>
	<criteria>age 1885 year compensate chronic liver disease suspect confirm liver cirrhosis send transjugular liver biopsy part routine care sign informed consent know contraindication performance HVPG measurement transjugular biopsy portal thrombosis previous surgical transjugular portosystemic shunt previous total partial splenectomy presence comorbid condition confer life expectancy le 1 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>portal hypertension</keyword>
	<keyword>cirrhosis</keyword>
	<keyword>ARFI</keyword>
	<keyword>diagnostic study</keyword>
</DOC>